Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Generex stock in Canada
Own Generex shares in just a few minutes.
Generex is a business based in the US. Generex stocks (GNBT.US) are listed on the OTCQB and all prices are listed in US Dollars. Its last market close was $0.053 – the same closing value as a week prior. Generex employs 15 staff and has a trailing 12-month revenue of around $692,762.
How to buy Generex stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – GNBT. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Finder Award
Interactive Brokers
- Access to international stock exchanges
- Low margin rates
- Powerful research tools
National Bank Direct Brokerage
- Commission-free trading
- Several account types available
- Access to array of research tools
What's in this guide?
- Can I buy shares in Generex?
- Has coronavirus impacted Generex shares?
- Generex shares summary
- Compare share dealing platforms
- Is Generex stock a buy or sell?
- Generex performance over time
- Generex's financials
- How volatile are Generex shares?
- Does Generex pay a dividend?
- Have Generex shares ever split?
- Other common questions
How has Coronavirus impacted Generex's stock price?
Since the stock market crash in March caused by coronavirus, Generex's stock price has had significant negative movement.
Its last market close was $0.0001, which is 99.98% down on its pre-crash value of $0.62 and 442,900.00% down on the lowest point reached during the March crash when the stocks fell as low as $0.443.
If you had bought $1,000 worth of Generex stocks at the start of February 2020, those stocks would have been worth $1,055.89 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $0.20.
Generex stock price
Use our graph to track the performance of GNBT stocks over time.Generex stocks at a glance
Information last updated 2022-12-29.
| Latest market close | $0.0001 |
|---|---|
| 52-week range | $0.0001 - $0.005 |
| 50-day moving average | $0.0009 |
| 200-day moving average | $0.0056 |
| Wall St. target price | $6 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.373 |
Buy Generex stocks from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Note: The dollar amounts in the table below are in Canadian dollars.
1 - 5 of 5
Generex price performance over time
Historical closes compared with the last close of $0.0001
| 3 months (2022-12-23) | 0.0001 |
|---|---|
| 6 months (2022-09-23) | -90.00% |
| 1 year (2022-03-23) | -96.67% |
|---|---|
| 2 years (2021-03-23) | -99.97% |
| 3 years (2020-03-23) | -99.98% |
| 5 years (2018-03-23) | -100.00% |
Generex financials
| Revenue TTM | USD$692,762 |
|---|---|
| Gross profit TTM | USD$2.1 million |
| Return on assets TTM | -43.84% |
| Return on equity TTM | -1772.71% |
| Profit margin | 0% |
| Book value | $-0.484 |
| Market capitalisation | USD$71,068 |
TTM: trailing 12 months
Generex stock dividends
We're not expecting Generex to pay a dividend over the next 12 months. However, you can browse other dividend-paying stocks in our guide.
Have Generex stocks ever split?
Generex stocks were split on a 7:5 basis on 25 February 2020. So if you had owned 5 shares the day before before the split, the next day you'd have owned 7 shares. This wouldn't directly have changed the overall worth of your Generex stocks – just the quantity. However, indirectly, the new 28.6% lower stock price could have impacted the market appetite for Generex stocks which in turn could have impacted Generex's stock price.
Generex stock price volatility
Over the last 12 months, Generex's stocks have ranged in value from as little as $0.0001 up to $0.005. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a stocks volatility in relation to the market. The market (OTCQB average) beta is 1, while Generex's is -0.0623. This would suggest that Generex's stocks have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Generex has bucked the trend.
Generex overview
Generex Biotechnology Corporation, through its subsidiaries, engages in the administration of formulations of large molecule drugs to the oral cavity using a hand-held aerosol applicator in Canada and the United States. It offers Generex Oral-lyn, an oral insulin product. The company is also developing AE37, a synthetic peptide vaccine, which has completed Phase IIb clinical trial to stimulate a potent and specific immune response against tumors expressing the HER-2/neu oncogene in patients with breast cancer and prostate cancer. In addition, it develops, manufactures, and distributes rapid point-of-care in-vitro medical diagnostics for infectious diseases, such as human immunodeficiency virus, tuberculosis, malaria, hepatitis B, hepatitis C, syphilis, and others; and test kits and cassettes for testing infectious diseases, as well as Excellagen, a wound conforming gel. Further, the company is developing immunotherapeutic products and vaccines; and extracellular matrix hydrogel solution, a tissue engineered therapy for the treatment of Ulcerative Colitis. Additionally, it manufactures and sells foot and ankle surgical kits that include plates, screws, and tools; and distributes surgical supplies, orthopedic implants, artificial joints, and biologics, medical devices, and regenerative medicine products. It also serves as the general partner of the Management Services Organization. Generex Biotechnology Corporation was founded in 1983 and is headquartered in Miramar, Florida. On April 23, 2022, an involuntary petition for liquidation under Chapter 7 was filed against Generex Biotechnology Corporation in the U.S. Bankruptcy Court for the Southern District of Florida. On June 6, 2022, the involuntary petition was approved by the Court.
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing
How do ETFs work?
Your guide to how ETFs work and whether this type of investment is right for you.
Read more…
Best stock app for beginners
The best stock trading app for beginners is easy to use and offers free trades.
Read more…
How to read stock charts
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
Read more…More guides on Finder
-
How to buy Neuraxis (NRXS) stock in Canada when it goes public
Everything we know about the Neuraxis IPO plus information on how to buy in.
-
How to buy Brera (BREA) stock in Canada
Everything we know about the Brera IPO plus information on how to buy in.
-
How to buy TXO Energy (TXO) stock in Canada
Everything we know about the TXO Energy IPO plus information on how to buy in.
-
How do ETFs work?
Your guide to how ETFs work and whether this type of investment is right for you.
-
How to buy Torex Gold stock in Canada
Steps to owning and managing TXG stock, with 24-hour and historical pricing before you buy.
-
Best stock app for beginners
The best stock trading app for beginners is easy to use and offers free trades.
-
How to read stock charts
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
-
3 upcoming IPOs to watch in March 2023
An healthcare company, NFT tech developer and baby products retailer are among the IPOs expected to take place this month.
-
What are stocks?
Owning a stock means you own part of a company and can potentially grow your wealth. But there is a risk of loss.
-
Best time to buy stocks
The best time to buy stocks could be right after an IPO, during expansion periods or when other investors are buying or selling.